TWI262791B - 6-methoxy-2-naphthylacetic acid prodrugs - Google Patents

6-methoxy-2-naphthylacetic acid prodrugs

Info

Publication number
TWI262791B
TWI262791B TW089122555A TW89122555A TWI262791B TW I262791 B TWI262791 B TW I262791B TW 089122555 A TW089122555 A TW 089122555A TW 89122555 A TW89122555 A TW 89122555A TW I262791 B TWI262791 B TW I262791B
Authority
TW
Taiwan
Prior art keywords
methoxy
naphthylacetic acid
acid prodrugs
formula
composition
Prior art date
Application number
TW089122555A
Other languages
English (en)
Inventor
Nnochiri N Ekwuribe
Jennifer A Riggs
Original Assignee
Nobex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nobex Corp filed Critical Nobex Corp
Application granted granted Critical
Publication of TWI262791B publication Critical patent/TWI262791B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW089122555A 1999-10-27 2000-10-26 6-methoxy-2-naphthylacetic acid prodrugs TWI262791B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16186499P 1999-10-27 1999-10-27

Publications (1)

Publication Number Publication Date
TWI262791B true TWI262791B (en) 2006-10-01

Family

ID=22583099

Family Applications (1)

Application Number Title Priority Date Filing Date
TW089122555A TWI262791B (en) 1999-10-27 2000-10-26 6-methoxy-2-naphthylacetic acid prodrugs

Country Status (20)

Country Link
US (3) US6525098B1 (zh)
EP (2) EP1223926A2 (zh)
JP (2) JP2003512424A (zh)
KR (2) KR20020043249A (zh)
CN (2) CN1413106A (zh)
AU (2) AU1576101A (zh)
BR (2) BR0015121A (zh)
CA (2) CA2387098A1 (zh)
CZ (2) CZ20021435A3 (zh)
HK (2) HK1048256A1 (zh)
HU (2) HUP0203321A2 (zh)
IL (2) IL149258A0 (zh)
MX (2) MXPA02004355A (zh)
NO (2) NO20022000L (zh)
NZ (2) NZ518554A (zh)
PL (2) PL354895A1 (zh)
RU (2) RU2002113657A (zh)
TW (1) TWI262791B (zh)
WO (2) WO2001030334A2 (zh)
ZA (2) ZA200203231B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI262791B (en) * 1999-10-27 2006-10-01 Nobex Corp 6-methoxy-2-naphthylacetic acid prodrugs
US7163958B2 (en) * 2002-07-03 2007-01-16 Nitromed Inc. Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
US7244753B2 (en) * 2002-07-29 2007-07-17 Nitromed, Inc. Cyclooxygenase-2 selective inhibitors, compositions and methods of use
WO2010096320A2 (en) * 2009-02-18 2010-08-26 Bezwada Biomedical, Llc Controlled release of nitric oxide and drugs from functionalized macromers and oligomers
US8062653B2 (en) 2009-02-18 2011-11-22 Bezwada Biomedical, Llc Controlled release of nitric oxide and drugs from functionalized macromers and oligomers
AU2010232556A1 (en) * 2009-04-02 2011-11-03 Allergan, Inc. Prostaglandin E receptor antagonists
CN101928227A (zh) * 2009-12-16 2010-12-29 天津工业大学 6-甲氧基-2-萘乙酸与水杨酰苯胺类化合物的互联体前药制备方法及应用

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904682A (en) * 1967-01-13 1975-09-09 Syntex Corp 2-(6{40 -Methoxy-2{40 -naphthyl)acetic acid
US4009197A (en) 1967-01-13 1977-02-22 Syntex Corporation 2-(6-Substituted-2'-naphthyl) acetic acid derivatives and the salts and esters thereof
JPS5441587B1 (zh) * 1969-09-30 1979-12-08 Syntex Corp
DE2051012A1 (en) * 1970-10-17 1972-04-20 Syntex Corp., Panama 1,6-methano-(10)-annulenes - with anti-inflammatory analgesic antipyr hypocholesterolaemic and fibrinolytic activity
US3978116A (en) * 1971-11-04 1976-08-31 Syntex Corporation 2-naphthyl acetic acid derivatives and compositions and methods thereof
US3883662A (en) * 1973-03-29 1975-05-13 Syntex Corp Method for delaying the onset of, or postponing, parturition
US4327022A (en) * 1973-08-16 1982-04-27 Sterling Drug Inc. Heterocyclic alkyl naphthols
US4420639C1 (en) 1973-09-11 2001-08-21 Beecham Group Ltd Aromatic compounds
US4061779A (en) 1973-09-11 1977-12-06 Beecham Group Limited Naphthalene derivatives having anti-inflammatory activity
EP0003074B1 (en) 1978-01-07 1981-04-15 Beecham Group Plc Process for the preparation of 4-(6-methoxy-2-naphthyl)butan-2-one and 2-acetyl-3-(6-methoxy-2-naphthyl) propenoic acid esters
US4246193A (en) 1979-11-26 1981-01-20 Syntex Corporation Process for the resolution of d,1 2-(6-methoxy-2-naphthyl)propionic acid
CH641432A5 (de) 1978-07-19 1984-02-29 Syntex Pharma Int Verfahren zur aufspaltung von racemischer 6-methoxy-alpha-methyl-2-naphthalinessigsaeure in die optischen antipoden.
US4268442A (en) 1978-11-14 1981-05-19 Sagami Chemical Research Center Process for preparing aromatic acetic acid
EP0011925B1 (en) * 1978-11-23 1982-09-22 Beecham Group Plc Naphthalene derivatives, a process for their preparation and their use in anti-inflammatory pharmaceutical compositions
IT1109200B (it) 1979-02-20 1985-12-16 Montedison Spa Processo per la preparazione di esteri di acidi arilacetici da alfa-alo-alchilarilchetoni
US4515811A (en) 1979-07-06 1985-05-07 Syntex Corporation Process for the resolution of d,1 2-(6-methoxy-2-naphthyl)propionic acid
IT1168387B (it) 1981-04-01 1987-05-20 Alfa Farmaceutici Spa Procedimento per la preparazione dell'acido 2-(6-metossi-2-naftil)-propionico
US4542237A (en) 1981-04-30 1985-09-17 Syntex Pharmaceuticals International Limited Manufacture of alpha-arylalkanoic acids and precursors
US4654438A (en) 1981-04-30 1987-03-31 Syntex Pharmaceuticals International Limited Manufacture of alpha-arylalkanoic acids and precursors
IT1190741B (it) 1982-03-22 1988-02-24 Blaschim Spa Procedimento per preparare esteri dell'acido 2-(6'-metossi-2'-naftil)-propionico
IT1210947B (it) 1982-11-03 1989-09-29 Zambon Spa Procedimento per preparare esteri di acidi arilalcanoici
US4723033A (en) 1982-11-24 1988-02-02 Syntex Pharmaceuticals International Ltd. Manufacture of optically active α-arylalkanoic acids and precursors thereof
IL67445A (en) * 1982-12-09 1985-11-29 Teva Pharma Ethoxycarbonyloxy ethyl esters of non-steroidal anti-inflammatory carboxylic acids
IT1164319B (it) 1983-07-27 1987-04-08 Blaschim Spa Procedimento per la risoluzione dell'acido (+-)2-(6'-metossi-2'-naftil)-propionico
JPS6081145A (ja) 1983-10-11 1985-05-09 Nissan Chem Ind Ltd ｄ−α−（６−メトキシ−２−ナフチル）プロピオン酸エステルのアルカリ性加水分解による，ｄ−α−（６−メトキシ−２−ナフチル）プロピオン酸の製法
US4661525A (en) 1984-03-28 1987-04-28 Texaco Inc. Process for producing lower aliphatic alcohols
GB8416638D0 (en) 1984-06-29 1984-08-01 Beecham Group Plc Topical treatment and composition
ES8700649A1 (es) 1984-07-11 1986-11-16 Blaschim Spa Procedimiento para la preparacion de acidos arilalcanoicos
US4670586A (en) 1984-09-12 1987-06-02 Nippon Chemicals Co., Ltd. Method for the production of α-aryl-alkanoic acid
EP0176142B1 (en) 1984-09-24 1991-11-27 Nobel Chemicals AB Process for the preparation of aryl alkyl ketones
IT1183626B (it) 1985-05-14 1987-10-22 Vamp Srl Prodotti polimerici autoestinguenti a base di poliolefine
IT1201443B (it) 1985-07-31 1989-02-02 Zambon Spa Intermedi per la sintesi di acidi carbossilici
JPH064561B2 (ja) 1986-02-08 1994-01-19 日本石油化学株式会社 （置換アリ−ル）カルボン酸の製造方法
CA1286316C (en) 1986-02-08 1991-07-16 Isoo Shimizu Method for refining 2-(aryl substituted)-propionic acid or its salt
IT1197800B (it) 1986-08-01 1988-12-06 Zambon Spa Processo per la sintesi di acidi carbossilici
IT1198234B (it) 1986-12-23 1988-12-21 Zambon Spa Processo stereoconvergente per la preparazione di acidi carbossilici otticamente attivi
US5202495A (en) 1987-03-26 1993-04-13 Callander Sidney E Chemical process
IT1222013B (it) 1987-07-10 1990-08-31 Chimica Profarmaco Spa Ind Processo di risoluzione ottica di acido 2 (6 metossi 2 naftil) propionico
US5225603A (en) 1987-07-14 1993-07-06 Hoechst Celanese Corporation Preparation of 4-(6'-methoxy-2'-naphthyl)-3-buten-2-one
JP2518014B2 (ja) 1988-05-31 1996-07-24 日産化学工業株式会社 α−置換酢酸の精製方法
GB8915104D0 (en) 1989-06-30 1989-08-23 Beecham Group Plc Chemical process
NL9001703A (nl) 1990-07-27 1992-02-17 Westspur Investment Ltd Werkwijze voor de bereiding van s(+)-6-methoxy-alfa-methyl-2-naftaleen-azijnzuur.
KR930003864B1 (ko) 1990-10-19 1993-05-14 한국과학기술연구원 d-2-(6-메톡시-2-나프틸)-프로피온산의 제조방법
US5179208A (en) 1990-10-19 1993-01-12 Korea Institute Of Science And Technology Process for preparing d-2-(6-methoxy-2-naphthyl)-propionic acid and intermediate thereof
DE69210323T3 (de) 1991-07-31 1999-06-02 Tessenderlo Chemie N.V., Bruxelles Verfahren zur Alpha-Monoalkierung von Arylacetonitrilen, Arylacetoestern und Arylessigsäuren
US5248815A (en) 1991-12-27 1993-09-28 Paradies Henrich H Stereo-selective synthesis of 2-aryl-propionic acids of high optical purity by using chiral oxazolines
GB9201857D0 (en) 1992-01-29 1992-03-18 Smithkline Beecham Plc Novel compound
FR2686876B1 (fr) 1992-02-04 1994-05-13 Hoechst Ste Francaise Procede de preparation d'acides arylacetiques et de leurs sels de metaux alcalins.
IT1256345B (it) 1992-08-20 1995-12-01 Esteri nitrici di derivati dell'acido 2-(2,6-di-alo-fenilammino) fenilacetico e procedimento per la loro preparazione
IT1256450B (it) 1992-11-26 1995-12-05 Soldato Piero Del Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
US5223640A (en) 1992-12-23 1993-06-29 Hoechst Celanese Corporation Preparation of optically active α-aryl propionic acids
GB9314693D0 (en) 1993-07-15 1993-08-25 Smithkline Beecham Plc Naphthyl derivatives for treatment method
HU218923B (hu) 1993-10-06 2000-12-28 Nicox S.A. Gyulladásgátló és/vagy fájdalomcsillapító hatású nitrát-észterek, ezeket tartalmazó gyógyszerkészítmények és eljárás a vegyületek előállítására
RU2145595C1 (ru) 1994-05-10 2000-02-20 Никокс С.А. Нитроксисоединения и фармацевтическая композиция на их основе, имеющие противовоспалительную, анальгетическую и антитромбоцитарную активности
US5426243A (en) 1994-08-17 1995-06-20 Albemarle Corporation Process for preparing 1,6-dibromo-2-naphthylene compounds
US5703073A (en) 1995-04-19 1997-12-30 Nitromed, Inc. Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
US5600009A (en) 1996-04-09 1997-02-04 Hoechst Celanese Corporation Use of 4-substituted 2-butanones to prepare nabumetone
AU7324696A (en) 1995-11-17 1997-06-11 Aeci Limited Synthesis of propionic acid derivatives
IT1285567B1 (it) 1996-02-21 1998-06-18 Alfa Chem Ital Nuovo processo per la sintesi del nabumetone
IT1282686B1 (it) 1996-02-26 1998-03-31 Nicox Sa Composti in grado di ridurre la tossicita' da farmaci
IT1283638B1 (it) 1996-07-29 1998-04-23 Archimica Spa Procedimento per la preparazione di un naftilbutanone
US5756851A (en) 1996-10-21 1998-05-26 Albemarle Corporation Production of nabumetone or precursors thereof
US5792886A (en) 1997-01-08 1998-08-11 Albemarle Corporation Production of racemic 2-(6-methoxy-2-naphthyl) propionic acid of precursors thereof
US5741938A (en) 1997-02-21 1998-04-21 Albemarle Corporation Production of alkyl aralkyl keones from allylic-aralkenyl secondary alcohols
ATE231128T1 (de) * 1997-02-21 2003-02-15 Takeda Chemical Industries Ltd Verbindungen mit kondensierten ringen, verfahren zu ihrer herstellung und ihre anwendung
US5847225A (en) 1997-04-25 1998-12-08 Albemarle Corporation Production of naphthyl-substituted ketones from naphthaldehydes
IT1291284B1 (it) 1997-04-30 1999-01-07 Secifarma Spa Processo per la preparazione del 4-(6'-metossi-2'-naftil)butan-2-one (nabumetone).
US5861538A (en) 1997-08-04 1999-01-19 Albemarle Corporation Production of alkoxynaphthyl-substituted ketones from naphthaldehydes
US5874614A (en) 1997-12-11 1999-02-23 Albemarle Corporation Sodium (S)-2-(6-methoxy-2-naphthyl)propionate monohydrate
US6436990B1 (en) * 1999-10-27 2002-08-20 Nobex Corporation 6-methoxy-2-naphthylacetic acid prodrugs
US6552078B2 (en) * 1999-10-27 2003-04-22 Nobex Corp 6-methoxy-2-naphthylacetic acid prodrugs
TWI262791B (en) * 1999-10-27 2006-10-01 Nobex Corp 6-methoxy-2-naphthylacetic acid prodrugs

Also Published As

Publication number Publication date
CN1413106A (zh) 2003-04-23
IL149258A0 (en) 2002-11-10
CZ20021433A3 (cs) 2002-08-14
US20030069309A1 (en) 2003-04-10
CZ20021435A3 (cs) 2002-08-14
EP1223926A2 (en) 2002-07-24
NZ518554A (en) 2004-05-28
NO20022000D0 (no) 2002-04-26
WO2001030338A2 (en) 2001-05-03
PL354510A1 (en) 2004-01-26
EP1223922A2 (en) 2002-07-24
JP2003512425A (ja) 2003-04-02
BR0015122A (pt) 2002-07-09
WO2001030334A2 (en) 2001-05-03
JP2003512424A (ja) 2003-04-02
CA2389181A1 (en) 2001-05-03
ZA200203231B (en) 2003-07-23
BR0015121A (pt) 2002-07-02
US6525098B1 (en) 2003-02-25
NZ518553A (en) 2004-02-27
AU2919601A (en) 2001-05-08
RU2002113657A (ru) 2004-01-10
CA2387098A1 (en) 2001-05-03
MXPA02004355A (es) 2002-11-07
NO20022001D0 (no) 2002-04-26
IL149257A0 (en) 2002-11-10
KR20020043249A (ko) 2002-06-08
MXPA02004357A (es) 2002-11-07
KR20020043248A (ko) 2002-06-08
HU0203790D0 (en) 2002-12-28
ZA200203229B (en) 2003-07-23
HUP0203790A3 (en) 2003-05-28
CN1413108A (zh) 2003-04-23
WO2001030338A3 (en) 2002-01-31
WO2001030338A8 (en) 2002-11-21
PL354895A1 (en) 2004-03-22
HUP0203790A2 (hu) 2003-04-28
AU1576101A (en) 2001-05-08
RU2002113661A (ru) 2004-01-10
NO20022000L (no) 2002-06-27
HK1048257A1 (zh) 2003-03-28
US20050054735A1 (en) 2005-03-10
HUP0203321A2 (hu) 2003-02-28
WO2001030334A3 (en) 2002-03-21
HK1048256A1 (zh) 2003-03-28
NO20022001L (no) 2002-06-25

Similar Documents

Publication Publication Date Title
BG105880A (en) Compounds useful as anti-inflammatory agents
BG106586A (en) Pyrazolopyramidines as therapeutic agents
TR200200706T2 (tr) Nöropatik ağrı tedavisi için retigabin kullanımı.
ZA979961B (en) 5-HT1F agonists
SI1465626T1 (sl) Farmacevtski sestavki (komplet), ki obsegajo dihidropiridionske spojine in imunoregulacijsko (ali protivnetno) sredstvo, in njihove uporabe
EP0705100A4 (en) THERAPEUTIC SUBSTITUTED GUANIDINES
PT804252E (pt) Agentes queladores metalicos que contem monoaminas diamidas e tiois
SE9901272D0 (sv) New improved formulation
CY2431B1 (en) Novel phenanthridines substituted in the 6 position.
WO2000071516A3 (en) INHIBITORS OF FACTOR Xa
NZ513096A (en) Compositions for treating inflammatory response
AP2001002191A0 (en) 3,3- Biarylpiperine and 2,2-biarylmorpholine derivatives.
BG105256A (en) Muscarinic agonists and antagonists
BR9907655A (pt) Derivados de ácido di-hidróxi-hexanóico
PL316656A1 (en) Free halophantrin base for use in treating marsh-fever and compositions containing same
AU8020698A (en) Use of glucosamine and glucosamine derivatives for quick alleviation of itching or localized pain
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
TWI262791B (en) 6-methoxy-2-naphthylacetic acid prodrugs
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
PL340459A1 (en) Agonists of 5ht1f
IL111804A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of constipation
DE69929802D1 (en) Lta4 hydrolase-hemmer
NO20012169D0 (no) Forbindelser med veksthormonfrigjörende egenskaper
TWI226833B (en) Pharmaceutical composition for inhibiting bone resorption
BG105763A (en) Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors